Source: The New York Times
Researchers at MIT and UC San Francisco used machine learning to reverse-engineer viral design, generating synthetic bacteriophages that function in the lab but have no wild counterparts. This marks a shift from predicting protein folding to authoring functional biological code. The work shows that AI can move beyond pattern recognition into active creation of novel organisms, raising immediate questions about dual-use biosecurity: if academic teams can design functional viruses in months, the technical barriers to designing human pathogens shrink considerably, making governance frameworks around AI-assisted biology far more urgent than current regulatory structures assume.